BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33333735)

  • 1. Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the
    Sanoguera-Miralles L; Valenzuela-Palomo A; Bueno-Martínez E; Llovet P; Díez-Gómez B; Caloca MJ; Pérez-Segura P; Fraile-Bethencourt E; Colmena M; Carvalho S; Allen J; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco EA
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33333735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene
    Sanoguera-Miralles L; Bueno-Martínez E; Valenzuela-Palomo A; Esteban-Sánchez A; Llinares-Burguet I; Pérez-Segura P; García-Álvarez A; de la Hoya M; Velasco-Sampedro EA
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants.
    Valenzuela-Palomo A; Bueno-Martínez E; Sanoguera-Miralles L; Lorca V; Fraile-Bethencourt E; Esteban-Sánchez A; Gómez-Barrero S; Carvalho S; Allen J; García-Álvarez A; Pérez-Segura P; Dorling L; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco EA
    J Pathol; 2022 Mar; 256(3):321-334. PubMed ID: 34846068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
    J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants.
    Sanoguera-Miralles L; Valenzuela-Palomo A; Bueno-Martínez E; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; García-Álvarez A; Pérez-Segura P; Infante M; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco-Sampedro EA
    Clin Chem; 2024 Jan; 70(1):319-338. PubMed ID: 37725924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants.
    Bueno-Martínez E; Sanoguera-Miralles L; Valenzuela-Palomo A; Esteban-Sánchez A; Lorca V; Llinares-Burguet I; Allen J; García-Álvarez A; Pérez-Segura P; Durán M; Easton DF; Devilee P; Vreeswijk MP; de la Hoya M; Velasco-Sampedro EA
    J Pathol; 2022 Sep; 258(1):83-101. PubMed ID: 35716007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minigene Splicing Assays Identify 12 Spliceogenic Variants of
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Caloca MJ; Gómez-Barrero S; Velasco EA
    Front Genet; 2019; 10():503. PubMed ID: 31191615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Eight Spliceogenic Variants in BRCA2 Exon 16 by Minigene Assays.
    Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Acedo A; Velasco EA
    Front Genet; 2018; 9():188. PubMed ID: 29881398
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Bueno-Martínez E; Sanoguera-Miralles L; Valenzuela-Palomo A; Lorca V; Gómez-Sanz A; Carvalho S; Allen J; Infante M; Pérez-Segura P; Lázaro C; Easton DF; Devilee P; Vreeswijk MPG; de la Hoya M; Velasco EA
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200360
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons.
    Acedo A; Hernández-Moro C; Curiel-García Á; Díez-Gómez B; Velasco EA
    Hum Mutat; 2015 Feb; 36(2):210-21. PubMed ID: 25382762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants.
    Sanoguera-Miralles L; Llinares-Burguet I; Bueno-Martínez E; Ramadane-Morchadi L; Stuani C; Valenzuela-Palomo A; García-Álvarez A; Pérez-Segura P; Buratti E; de la Hoya M; Velasco-Sampedro EA
    J Pathol; 2024 Apr; 262(4):395-409. PubMed ID: 38332730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes.
    Acedo A; Sanz DJ; Durán M; Infante M; Pérez-Cabornero L; Miner C; Velasco EA
    Breast Cancer Res; 2012 May; 14(3):R87. PubMed ID: 22632462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splicing Analysis of 16
    Valenzuela-Palomo A; Sanoguera-Miralles L; Bueno-Martínez E; Esteban-Sánchez A; Llinares-Burguet I; García-Álvarez A; Pérez-Segura P; Gómez-Barrero S; de la Hoya M; Velasco-Sampedro EA
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from "Uncertain Significance" to "Pathogenic" based on minigene assays and clinical evidence.
    Ning Y; Zhang Y; Tian T; Chen Y; Wang J; Lei K; Cui Z
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):62. PubMed ID: 38300310
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Gailite L; Valenzuela-Palomo A; Sanoguera-Miralles L; Rots D; Kreile M; Velasco EA
    Front Genet; 2020; 11():169. PubMed ID: 32211025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing and ACMG-AMP-2015-based classification of PALB2 genetic variants: an ENIGMA report.
    Lopez-Perolio I; Leman R; Behar R; Lattimore V; Pearson JF; Castéra L; Martins A; Vaur D; Goardon N; Davy G; Garre P; García-Barberán V; Llovet P; Pérez-Segura P; Díaz-Rubio E; Caldés T; Hruska KS; Hsuan V; Wu S; Pesaran T; Karam R; Vallon-Christersson J; Borg A; ; Valenzuela-Palomo A; Velasco EA; Southey M; Vreeswijk MPG; Devilee P; Kvist A; Spurdle AB; Walker LC; Krieger S; de la Hoya M
    J Med Genet; 2019 Jul; 56(7):453-460. PubMed ID: 30890586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing Outcomes of 5' Splice Site GT>GC Variants That Generate Wild-Type Transcripts Differ Significantly Between Full-Length and Minigene Splicing Assays.
    Lin JH; Wu H; Zou WB; Masson E; Fichou Y; Le Gac G; Cooper DN; Férec C; Liao Z; Chen JM
    Front Genet; 2021; 12():701652. PubMed ID: 34422003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect.
    Dawson LM; Smith KN; Werdyani S; Ndikumana R; Penney C; Wiede LL; Smith KL; Pater JA; MacMillan A; Green J; Drover S; Young TL; O'Rielly DD
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1070. PubMed ID: 31782267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEPT-GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics.
    Alimohamed MZ; Boven LG; van Dijk KK; Vos YJ; Hoedemaekers YM; van der Zwaag PA; Sijmons RH; Jongbloed JDH; Sikkema-Raddatz B; Westers H
    Gene; 2023 Jan; 851():146984. PubMed ID: 36270459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.